ICOTYDE has been
extensively studied
in people 12 and older
Side effect rates
similar to placebo
in clinical studies at 16 weeks
In clinical studies, ICOTYDE was compared with a placebo, a treatment that looks like the study medicine but does not contain an active ingredient. This comparison helps researchers better understand the effects of ICOTYDE.
| Side effect | ICOTYDE* | Placebo* |
|---|---|---|
| Headache | 4.1% | 3.3% |
| Nausea | 1.2% | 0.5% |
| Cough | 1.2% | 0.2% |
| Fungal infection | ||
| Tinea | 0.5% | 0.0% |
| Other† | 0.8% | 0.0% |
| Tiredness | 1.0% | 0.5% |
These are not all the possible side effects of ICOTYDE.
Talk to your doctor about all possible side effects.
*In 4 clinical studies, 1296 people took ICOTYDE, and 568 people took a placebo.
†Includes oral candidiasis, onychomycosis, skin candida, urinary tract candidiasis, vulvovaginal candidiasis, fungal skin infection, genital infection fungal, ear infection fungal, and laryngitis fungal.
